In this Voices on Cancer post, patient advocate Gilliosa Spurrier Bernard shares her experience advocating for people with melanoma in France.
ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.
At the 2017 Clinical Immuno-Oncology Symposium, new research will be presented on the link between gut bacteria and immunotherapy for melanoma and the impact of tumor location in predicting survival from colorectal cancer.
The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.
Wrapping up our summer Research Round Up series, experts discuss advances in lung cancer and melanoma research.
Apostolia-Maria Tsimberidou, MD, PhD, discusses recent research presented at the 2016 American Association for Cancer Research (AACR) Annual Meeting.
Paul Chapman, MD, discusses the current treatments for metastatic melanoma and the direction of current research.
Expert-led podcasts explaining research on kidney cancer and melanoma, featuring Brian I. Rini, MD, and Paul Chapman, MD.
Ultraviolet (UV) radiation from the sun can damage the eyes, as well as the skin around them. Learn more about choosing the best sunglasses to help prevent cancer, cataracts, and conditions that can lead to vision loss.
Research Highlights on Immunotherapy for Melanoma and Cervical Cancer From the 2014 ASCO Annual Meeting
Activating and amplifying the body’s immune response to cancer is an exciting area of research. See how it is being used to better treat advanced or high-risk melanoma and cervical cancer in these four studies presented in Chicago today.